Japanese company Nipro Corp <8086.T> has recalled 2 million needles distributed in the United States for withdrawing blood, injecting medicines and other purposes, U.S. health officials said on ...

Japanese company Nipro Corp has recalled 2 million needles distributed in the United States that are used for withdrawing blood, injecting medicine and accessing ports under patients' skin for ...

United States Syringes & Needles Market Insights Report 2023: A $10.87 Billion Market by 2028 with BD, ICU Medical, Nipro Medical, Terumo, and Cardinal Health Emerging as Prominent Players - ...

Nipro is purchasing the 130-acre Pitt County-owned industrial site in Greenville. The facility will produce state-of-the-art dialyzers and precision needles for insulin and GLP-1 therapies.

Osaka, Japan-based Nipro Medical Corp. is investing $398 million to establish a new manufacturing facility in Greenville, N.C., to meet demand from the North American pharmaceutical and dialysis ...

PRESS RELEASE GlobeNewswire Oct. 23, 2019, 05:01 AM Dublin, Oct. 23, 2019 (GLOBE NEWSWIRE) -- The "Safety Needles Market by Product and End User: Global Opportunity Analysis and Industry Forecast ...

INCHEON, Korea, June 09, 2025--Samsung Bioepis Co., Ltd. ("Samsung Bioepis") announced today that the company has entered into a license, development and commercialization agreement with NIPRO ...

TheEurope Syringes & Needles Insights Report 2023: A $7.97 Billion Market in 2022 - Forecasts to 2028 with BD, CardinalHealth, B Braun, Nipro, and Terumo Dominating - ResearchAndMarkets.com ...

Dialyzers are used to perform therapeutic dialysis. Nipro will start upgrading its plant next month and start production of dialyzers in 2023, manufacturing six million in the first year before ...